What is Bicara Therapeutics's impairment charges?

Bicara Therapeutics (BCAX) reported impairment charges of $0 in Q4 2025.

What does impairment charges mean?

Write-downs of long-lived assets (excluding goodwill) when their carrying value exceeds fair value, including property, equipment, right-of-use assets, and other tangible assets.

Bicara Therapeutics BCAX Impairment Charges

Impairment Charges at other companies

Travel + LeisureTNL

$19M—

AtkoreATKR

$11.55M-91.0%

Gates Industrial CorporationGTES

$0-100%

Avis Budget GroupCAR

$129.5M-79.0%

Lincoln Educational Services CorporationLINC

$0—

Capri HoldingsCPRI

$19M-53.7%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.

The official record: Bicara Therapeutics’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's impairment charges?: Bicara Therapeutics (BCAX) reported impairment charges of $0 in Q4 2025.
What does impairment charges mean?: Write-downs of long-lived assets (excluding goodwill) when their carrying value exceeds fair value, including property, equipment, right-of-use assets, and other tangible assets.